Clinical Trials

26 enrolled 16 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00729118 2020-05-18

Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

19 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01245673 2020-04-06

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

28 enrolled 8 charts

Neoplasms, Plasma Cell

NCT00772915 2020-01-18

Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

39 enrolled 13 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00477750 2019-10-11

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase 1/2 Completed

33 enrolled 14 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00687674 2019-08-20

Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Terminated

13 enrolled 7 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01927718 2019-04-29

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

Phase NA Terminated

10 enrolled 5 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01191060 2019-04-18

IFM/DFCI2009

Phase 3 Completed

700 enrolled

Disease Progression, Neoplasms, Plasma Cell

NCT01440582 2019-03-04

Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients

77 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00790842 2018-10-24

PrE1003

Phase 1/2 Terminated

63 enrolled 14 charts

Phase EARLY_PHASE1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01861340 2018-09-10

Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma

20 enrolled

Neoplasms, Plasma Cell

NCT01554852 2018-06-11

Myeloma XI

Phase 3 Unknown

4,420 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00538824 2018-06-06

DexTR

Phase 2 Terminated

5 enrolled 8 charts

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT02419118 2017-11-07

DARA

Phase 2/3 Completed

4 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01042704 2017-07-31

Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

29 enrolled

Neoplasms, Plasma Cell

NCT01985477 2016-09-14

Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 1 Terminated

2 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00698776 2016-06-21

Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma

6 enrolled

Neoplasms, Plasma Cell

NCT01079936 2016-06-06

Lenalidomide and High-Dose Melphalan

Phase 1/2 Completed

61 enrolled 11 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02041325 2016-05-17

Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias

38 enrolled 9 charts

Neoplasms, Plasma Cell

NCT01501370 2016-05-10

ZLd_Ld

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00567229 2015-11-20

Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma

Phase 2 Terminated

3 enrolled 6 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00445484 2015-08-24

Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

22 enrolled 11 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00564889 2013-05-14

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

35 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00478218 2011-08-31

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

53 enrolled 13 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01002703 2011-08-12

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Unknown

50 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00093028 2010-07-02

Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II

Phase 3 Completed

315 enrolled